Wall Street rebounds, all eyes on Boston Reuters India O), which said Thursday that an experimental drug improved lung function in adults with cystic fibrosis in a midstage trial. Its shares surged nearly 59 percent to $83.85. (Reporting by Rodrigo Campos and Ryan Vlastelica; Editing by Kenneth Barry, Nick ... |
